Lifevantage Corporation
LFVN
Get informed when a big investor buys or sells
+ FollowMarket Cap$84.4M
Close$
$11.74
77% upside
Current Fair Value
77% upsideUndervalued by 77% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $84.40 Million |
|---|---|
| Enterprise Value | $82.12 Million |
| Dividend Yield | $0.18 (2.77%) |
| Earnings per Share | $0.8 |
| Beta | 0.76 |
| Outstanding Shares | 12,625,000 |
Return
| Return on Equity | 21.20% |
|---|---|
| Return on Assets | 11.38% |
| Return on Invested Capital | 20.46% |
Valuation & Multiples
| P/E Ratio | 14.49 |
|---|---|
| PEG | -23.85 |
| Price to Sales | 0.41 |
| Price to Book Ratio | 3.32 |
| Enterprise Value to Revenue | 0.4 |
| Enterprise Value to EBIT | 9.55 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$47.77 M
Average shareholder expectationNext Earnings Call
Expected Date
August 27, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$44.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.2713▲ 401.82% |
|---|---|
| Total Calls | 44,600▼ 57.40% |
| Total Puts | 190,500▲ 618.87% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 46.86%▼ 13.23% |
|---|---|
| Total Invested | $36.91M▲ 12.64% |
| Investors Holding | 95▼ 12.00% |
ESG Score
No data
About Lifevantage Corporation
CEO: Darren Jensen LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary suppl...